DrugPatentWatch Database Preview
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Drug Profile
Email this page to a colleague
When do Dorzolamide Hydrochloride And Timolol Maleate patents expire, and what generic alternatives are available?
Dorzolamide Hydrochloride And Timolol Maleate is a drug marketed by Akorn, Aurobindo Pharma Ltd, Bausch And Lomb, Fdc Ltd, Indoco, Lannett Co Inc, Micro Labs, Rubicon, Sandoz, Sandoz Inc, Somerset, Teva Pharms, and Zambon Spa. and is included in fourteen NDAs.
The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dorzolamide Hydrochloride And Timolol Maleate
A generic version of DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE was approved as dorzolamide hydrochloride; timolol maleate by AKORN on October 28th, 2008.
Summary for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 12 |
| Clinical Trials: | 9 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE? | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE excipients list |
| DailyMed Link: | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE at DailyMed |
Recent Clinical Trials for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida | Phase 1 |
| Allergan | Phase 3 |
| Meir Medical Center | N/A |
See all DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE clinical trials
Pharmacology for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
| Drug Class | Carbonic Anhydrase Inhibitor beta-Adrenergic Blocker |
| Mechanism of Action | Carbonic Anhydrase Inhibitors Adrenergic beta-Antagonists |
ATC Classes for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
US Patents and Regulatory Information for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 077847-001 | Oct 28, 2008 | AT | RX | No | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | |||
| Lannett Co Inc | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 201998-001 | Dec 17, 2014 | DISCN | No | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | ||||
| Bausch And Lomb | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 090037-001 | Jul 14, 2009 | AT | RX | No | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
